
Planning, budgeting, and outsourcing clinical trials are key elements in the life cycle of a biotech company. There are so many considerations: study or program level scenario planning is instrumental to sharpening clinical execution plans; R&D pipeline cost estimates are required for fund raising, CFO reporting, or R&D partnership discussions. Each asset is precious, so selecting the right CRO/clinical service provider and performing operational and budget-level due diligence is mission critical. All these aspects of clinical operations are common to biopharmaceutical companies, but the biotechs have additional challenges; they are usually short staffed, moving at light speed, and lack the clinical outsourcing infrastructure that larger companies have built over many years of running trials. Learn:
- How to overcome common challenges in clinical study planning and budgeting
- Methodologies for effectively conducting CRO proposal due diligence and getting over analysis hurdle
- Reviewing/changing your approach and your process
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence

Webinars
Technology for Fast, Accurate Planning and Budgeting
Leading biopharmaceutical sponsors trust PORTFOLIO for pipeline planning and budgeting with superior results and reported more than 10x Return on Investment.

Blogs
Driving Customer Success Through Governance: Transforming Pharma Vendor Management with AI Innovation
Effective vendor governance is essential to ensure operational success, cost efficiency, and regulatory compliance.

Case Studies
Streamlining Vendor Management: How a Leading Biopharma Company Found Success
DEMO
Request a demo
Discover how Strategikon’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.